Congenital muscular dystrophy type 1A with residual merosin expression
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김효정 | - |
dc.contributor.author | 최영철 | - |
dc.contributor.author | 박형준 | - |
dc.contributor.author | 이영목 | - |
dc.contributor.author | 김흥동 | - |
dc.contributor.author | 이준수 | - |
dc.contributor.author | 강훈철 | - |
dc.date.accessioned | 2021-09-23T00:41:31Z | - |
dc.date.available | 2021-09-23T00:41:31Z | - |
dc.date.created | 2021-09-23 | - |
dc.date.issued | 2014-03 | - |
dc.identifier.issn | 1738-1061 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/82197 | - |
dc.description.abstract | Congenital muscular dystrophy type 1A (MDC1A) is an autosomal recessive disorder characterizedby hypotonia, elevated serum creatine kinase level, delayed motor milestones, white matter changesobserved by brain magnetic resonance imaging, and normal intelligence. A mutation in the laminin α2(LAMA2 ) gene, located at 6q22-23, is a genetic cause of MDC1A. Patients have merosin (laminin α2)-deficient skeletal muscles. However, the degree of merosin expression ranges from total absence topartial reduction. Patients with residual merosin expression have more variable and milder phenotypesthan those with absolute merosin deficiency. We observed a Korean girl with MDC1A with residualmerosin expression. Clinical presentation of this patient was typical except for late onset of the diseaseand external capsule involvement. Immunohistochemical staining of muscle fibers including merosin, isimportant to evaluate patients with hypotonia, delayed motor development, and abnormal white matterchanges. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | 대한소아청소년과학회 | - |
dc.relation.isPartOf | Clinical and Experimental Pediatrics | - |
dc.title | Congenital muscular dystrophy type 1A with residual merosin expression | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.doi | 10.3345/kjp.2014.57.3.149 | - |
dc.identifier.bibliographicCitation | Clinical and Experimental Pediatrics, v.57, no.3, pp.149 - 152 | - |
dc.identifier.kciid | ART001859073 | - |
dc.description.isOpenAccess | N | - |
dc.identifier.scopusid | 2-s2.0-84896454282 | - |
dc.citation.endPage | 152 | - |
dc.citation.startPage | 149 | - |
dc.citation.title | Clinical and Experimental Pediatrics | - |
dc.citation.volume | 57 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | 김효정 | - |
dc.subject.keywordAuthor | Merosin-deficient congenital muscular dystrophy | - |
dc.subject.keywordAuthor | Laminin alpha2 | - |
dc.subject.keywordAuthor | Immunohistochemistry | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.